Therefore, inhibiting the activation and proliferation of HSCs and inducing apoptosis of activated HSCs by targeting the PI3K/Akt/mTOR signaling pathway has become one of the main strategies for treating liver fibrosis. This evidence concerns the gene MTOR and Hepatic fibrosis.